Abstracts Archive - Page 2288 of 2425 - ACR Meeting Abstracts

Abstract Number: 2004 • 2012 ACR/ARHP Annual Meeting
Do We Need a Minimum Standards in Care for Children with Localized Scleroderma- Result of the Consensus Meeting in Hamburg Germany On the 11th of December 2011. Part I. Diagnosis and Assessment of the Disease
Ivan Foeldvari¹, Tamás Constantin², Peter Hoeger³, Monika Moll⁴, Clare Pain⁵, Dana Nemcova⁶, Kathryn S. Torok⁷, Lisa Weibel⁸ and Philip J. Clements⁹, ¹Kinder- und Jugenrheumatologie, Hamburger Zentrum Kinder-und Jugendrheumatologie, Hamburg, Germany, ²Pediatric Rheumatology, Semmelweis Egyetem, AOK, II.sz. Gyermekgyogyaszati Klinika, Budapest, Hungary, ³Pediatric Dermatology, Kinderkrankenhaus Wilhelmstift, Hamburg, Germany, ⁴Pediatric Rheumatology, University Childrenxsxhospital, Tübingen, Germany, ⁵Paediatric Rheumatology, Alder Hey Children's Hospital, Liverpool, United Kingdom, ⁶Pediatric Rheumatology, University Childrenxsxhospital, Prague, Czech Republic, ⁷Pediatric Rheumatology, Scleroderma Center of Pittsburgh, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ⁸Pediatric Dermatology, University Childrenxs Hospital, Zurich, Switzerland, ⁹University of California, Los Angeles, Department of Medicine, Los Angeles, CA
Background/Purpose: Juvenile localised scleroderma (jlSc) is an orphan disease. There are currently no guidelines regarding diagnosis, follow up and treatment. In the frame of the…
Abstract Number: 2005 • 2012 ACR/ARHP Annual Meeting
Clinical Course and Outcomes of Children with Juvenile Idiopathic Arthritis-Associated Uveitis and Idiopathic Uveitis
Sheila T. Angeles-Han¹, Steven Yeh², Courtney McCracken³, Larry B. Vogler⁴, Kelly A. Rouster-Stevens⁵, Christine W. Kennedy⁶, Matthew Kent⁴, Kirsten Jenkins⁷, Scott Lambert⁸, Carolyn Drews-Botsch⁹ and Sampath Prahalad¹⁰, ¹Pediatrics, Emory Univ School of Medicine, Atlanta, GA, ²Ophthalmology, Emory University School of Medicine, Atlanta, GA, ³Emory University School of Medicine, Atlanta, GA, ⁴Dept of Pediatrics, Emory Univ School of Medicine, Atlanta, GA, ⁵Pediatric Rheumatologist, Emory Children's Center, Atlanta, GA, ⁶Rheumatology Immunology, Emory Children's Center, Atlanta, GA, ⁷Children's Healthcare of Atlanta, Atlanta, GA, ⁸Ophthalmology, Emory Univ School of Medicine, Atlanta, GA, ⁹Epidemiology, Emory University School of Public Health, Atlanta, GA, ¹⁰Pediatrics, Emory Children's Center, Atlanta, GA
Background/Purpose: Uveitis can lead to vision loss and blindness. Few studies focus on the outcomes of children with both juvenile idiopathic arthritis-associated uveitis (JIA-U) and…
Abstract Number: 2006 • 2012 ACR/ARHP Annual Meeting
Sexual Health and Substance Abuse in Adolescents with Rheumatic Conditions
Sara M. Stern¹, Rhina Castillo², Katherine AB Marzan², Jennifer Jackson³, Mona Desai³, Ellen Iverson³, Leslie F. Clark³ and Diane Tanaka³, ¹Pediatric Rheumatology, Children's Hospital Los Angeles, Los Angeles, CA, ²Division of Rheumatology, Children's Hospital Los Angeles, Los Angeles, CA, ³Division of Adolescent Medicine, Children's Hospital Los Angeles, Los Angeles, CA
Background/Purpose: Adolescence is a unique stage with pubertal maturation, individuation from parents and peer group identification. The impact of a rheumatic condition can affect social,…
Abstract Number: 2007 • 2012 ACR/ARHP Annual Meeting
Radiological Peripheral Involvement At Hands, Feet and Hips in Young Adults with Polyarticular Idiopathic Juvenile Arthritis
Muriel Elhai¹, Ramin Bazeli², Veronique Freire², Antoine Feydy², Andre Kahan³, Chantal Job-Deslandre⁴ and Julien Wipff¹, ¹Rheumatology A, Paris Descartes University, Cochin Hospital, APHP, Paris, France, ²Radiology B, Paris Descartes University, Cochin Hospital, APHP, Paris, France, ³Service de Rhumatologie A, Rheumatology A, Paris Descartes University, Cochin Hospital, APHP, Paris, France, ⁴Service de Rhumatologie, Rheumatology A, Paris Descartes University, Cochin Hospital, APHP, Paris, France
Background/Purpose: Radiographic damage was recently considered to be a feature of poor prognosis in cases of polyarticular juvenile idiopathic arthritis (pJIA). However, most radiographic studies…
Abstract Number: 2008 • 2012 ACR/ARHP Annual Meeting
Initial Evaluation of a Localized Scleroderma (LS) Clinical Activity Measure
Suzanne C. Li¹, Kathryn S. Torok², Christina Kelsey³, Mara L Becker⁴, Fatma Dedeoglu⁵, Robert C. Fuhlbrigge⁶, Gloria C. Higgins⁷, Sandy D. Hong⁸, Maria F. Ibarra⁹, Ronald Laxer¹⁰, Thomas G. Mason II¹¹, Marilynn G. Punaro¹², Elena Pope¹³, C. Egla Rabinovich¹⁴ and Katie G. Stewart¹², ¹Pediatrics, Joseph M Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, NJ, ²Pediatric Rheumatology, Scleroderma Center of Pittsburgh, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ³Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, ⁴Clinical Pharmacology and Rheumatology, Children's Mercy Hospital, Kansas City, MO, ⁵Division of Immunology, Boston Children's Hospital, Boston, MA, ⁶Pediatric Rheumatology, Childrens Hospital, Boston, MA, ⁷Pediatric Rheumatology Ohio State University, Nationwide Childrens Hosp, Columbus, OH, ⁸Pediatrics-Rheumatology, U of Iowa Children's Hosp, Iowa City, IA, ⁹Pediatric Rheumatolgy, Children's Mercy Hospital, Kansas City, MO, ¹⁰Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ¹¹Rheumatology, Mayo Clinic Rochester, Rochester, MN, ¹²Pediatric Rheumatology, Texas Scottish Rite Hospital, Dallas, TX, ¹³Dermatology, The Hospital for Sick Children, Toronto, ON, Canada, ¹⁴Pediatric Rheumatology, Duke University Medical Center, Durham, NC
Background/Purpose: LS commonly causes severe morbidity for the growing child. Optimal therapy is not known and the lack of an agreed-upon standard for assessing disease…
Abstract Number: 2009 • 2012 ACR/ARHP Annual Meeting
Does Breastfeeding Influence the Presentation of Juvenile Idiopathic Arthritis? Results From the Childhood Arthritis Prospective Study
Hannah Pickford¹, Eileen Baildam², Alice Chieng³, Joyce Davidson⁴, Helen E. Foster⁵, Janet Gardner-Medwin⁴, Lucy R. Wedderburn⁶, Wendy Thomson¹ and Kimme L. Hyrich⁷, ¹University of Manchester, Arthritis Research UK Epidemiology Unit, Manchester, United Kingdom, ²Alder Hey Children's Foundation NHS Trust, Liverpool, United Kingdom, ³Manchester Children's Hospital, Manchester, United Kingdom, ⁴Royal Hospital for Sick Children, Glasgow, United Kingdom, ⁵Institute Cellular Medicine, Musculoskeletal Research Group, Newcastle upon Tyne, United Kingdom, ⁶Rheumatology Unit , Institute of Child Health, University College London (UCL), London, United Kingdom, ⁷Manchester Academic Health Science Centre, Arthritis Research UK Epidemiology Unit, Manchester, United Kingdom
Background/Purpose: There is extensive research into the association between breastfeeding (BF) and the occurrence of autoimmune diseases, although results have been conflicting. Studies have suggested…
Abstract Number: 2010 • 2012 ACR/ARHP Annual Meeting
Administration of Routine Preventative Vaccinations in Children with Juvenile Idiopathic Arthritis Receiving Adalimumab
Neelufar Mozaffarian¹ and Vipin Arora², ¹Abbott, Abbott Park, IL, ²Health Outcomes Research, Abbott, Abbott Park, IL
Background/Purpose: Adalimumab, a fully human monoclonal antibody to tumor necrosis factor-alpha (TNF) has been shown to be safe and effective in juvenile idiopathic arthritis (JIA),…
Abstract Number: 2011 • 2012 ACR/ARHP Annual Meeting
ACR Criteria, Providers’ Global Rating of Change and Role of Patient Self-Report in Evaluating Change in Disease Over Time: A Patient Reported Outcomes Measurement Information System Study
Bin Huang¹, Jennifer Farrell², Adam Carle³, Stacey Niehaus³, Hermine Brunner⁴, Alexei A. Grom⁵, Michael Henrickson⁶, Jennifer L. Huggins⁴, D. J. Lovell⁷, Tracy V. Ting⁴ and Esi M. Morgan DeWitt², ¹Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center/University of Cincinnati School of Medicine, Cincinnati, OH, ²Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ³Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁴Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁵PRCSG, Cincinnati, OH, ⁶MLC 4010, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁷Cincinnati Children's Hospital, Cincinnati, OH
Background/Purpose: As part of a longitudinal study of Juvenile Idiopathic Arthritis (JIA), providers completed clinical outcomes assessments and patients (pt) completed self-report measures at clinic…
Abstract Number: 2012 • 2012 ACR/ARHP Annual Meeting
Pediatric Rheumatology Productivity: Results of the American Academy of Pediatrics 2010 Workforce Survey
Michael Henrickson¹ and Laura Laskosz², ¹MLC 4010, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²Division of Technical and Medical Services, The American Academy of Pediatrics, Elk Grove Village, IL
Background/Purpose: Relative value units (RVUs) are a payer-neutral measure of clinical work. The federal government uses a multi-component formula to convert this measure into reimbursement.…
Abstract Number: 2013 • 2012 ACR/ARHP Annual Meeting
Cross-Sectional and Longitudinal comparison of Bone Mass Status, Using pQCT, in a Large Cohort of Juvenile Idiopathic Arthritis and Juvenile Onset Systemic Lupus Erythematosus Patients
Fernanda Falcini¹, Stefano Stagi², Loredana Cavalli³, Giulia Carnesecchi⁴, Federico Bertini⁴, Laura Masi³, Marco Matucci-Cerinic⁵ and Maria Luisa Brandi³, ¹Department of Biomedicine, Division of Rheumatology AOUC, Excellence Centre for Research, Florence, Italy, ²Pediatric Unit,, Mugello's Hospital, Borgo San Lorenzo, Firenze, Italy, ³Department of Internal Medicine, Endocrinology Unit, University of Florence, Firenze, Italy, ⁴Department of Internal Medicine, Rheumatology Section, University of Florence, Florence, Italy, ⁵Medicine, Univ Florence, Firenze, Italy
Background/Purpose: A small number of prospective data have been published on the use of pQCT in large groups of pts with JIA and JSLE. Moreover,…
Abstract Number: 2014 • 2012 ACR/ARHP Annual Meeting
Serum 25(OH)D Levels in Adolescents and Young Adults with Juvenile Idiopathic Arthritis and Juvenile Onset Systemic Lupus Erythematosus: Prevalence and Association with Disease Activity
Fernanda Falcini¹, Stefano Stagi², Loredana Cavalli³, Giulia Carnesecchi¹, Federico Bertini¹, Laura Masi³, Marco Matucci-Cerinic¹ and Maria Luisa Brandi³, ¹Department of Internal Medicine, Rheumatology Section, Transition Clinic, University of Florence, Florence, Italy, ²Pediatric Endocrinology Unit, Anna Meyer Children’s Hospital, University of Florence, Firenze, Italy, ³Department of Internal Medicine, Endocrinology Unit, University of Florence, Firenze, Italy
Background/Purpose: Numerous data are available in literature on 25 (OH)D serum levels in general population, few and contradictory in Juvenile Idiopathic Arthritis (JIA), and scarce…
Abstract Number: 2015 • 2012 ACR/ARHP Annual Meeting
Recognizing Two Distinct Clinical Phenotypes in Muckle-Wells Syndrome
J B. Kuemmerle-Deschner¹, Samuel Dembi Samba¹, Isabelle Kone-Paut², Isabelle Marie², Pascal N. Tyrrell³ and Susanne M. Benseler⁴, ¹Division of Pediatric Rheumatology, Department of Pediatrics, University Hospital Tuebingen, Tuebingen, Germany, ²Pédiatrie Générale, CHU Bicêtre, Paris, France, ³Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ⁴Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada
Background/Purpose: The diagnosis of Muckle-Wells syndrome remains challenging due to the variable and often non-specific clinical presentation. The aim of this study was to identify…
Abstract Number: 2016 • 2012 ACR/ARHP Annual Meeting
Primary Raynaud’s Phenomenon in a Multicenter Cohort of Italian Children and Adolescents: Which Prognostic Relevance for Serological Tests?
Fernanda Falcini¹, Valentina Denaro¹, Federica Cuoco², Giorgia Martini³, Susanna Cappelli¹, Antonella Petaccia², Fabrizia Corona², Giulia Carnesecchi¹, Francesco La Torre⁴, Marco Matucci-Cerinic⁵ and Donato Rigante⁶, ¹Department of Internal Medicine, Rheumatology Section, University of Florence, Firenze, Italy, ²Department of Pediatrics, University of Milan, Milan, Italy, ³Department of Pediatrics,, University of Padua, Padua, Italy, ⁴DIMIMP-University, Rheumatologic Section, Bari, Italy, ⁵Department of Biomedicine & Division of Rheumatology AOUC, University of Florence, Florence, Italy, ⁶Pediatrics, Università Cattolica Sacro Cuore, Rome, Italy
Background/Purpose: Raynaud’s phenomenon (RP) is an episodic vasospasm of the peripheral arteries, causing pallor followed by cyanosis and redness with pain and sometimes paraesthesia or…
Abstract Number: 2017 • 2012 ACR/ARHP Annual Meeting
Orthopaedic Treatment of Temporomandibular Joint (TMJ) Damage in Adolescents with Juvenile Idiopathic Arthritis (JIA): Longitudinal Evaluation
Fernanda Falcini¹, Daniela Melchiorre², Giulia Carnesecchi³, Federico Bertini⁴, Katia Biondi⁵, Mario Bosco⁵ and Marco Matucci-Cerinic⁶, ¹Department of Biomedicine, Division of Rheumatology AOUC, Excellence Centre for Research, Florence, Italy, ²Department of Biomedicine, Division of Rheumatology, Department of Internal Medicine, Rheumatology Section, University of Florence, Florence, Italy, ³Department of Biomedicine, Division of Rheumatology, University of Florence, Florence, Italy, ⁴Department of Internal Medicine, Rheumatology Section, University of Florence, Florence, Italy, ⁵Department of Odontostomatologic Sciences, University of Pavia, Pavia, Italy, ⁶Department of Biomedicine & Division of Rheumatology AOUC, University of Florence, Florence, Italy
Background/Purpose: TMJ involvement has been reported in all subsets of JIA. The prevalence of radiographic changes of TMJs varies from 30% to 65%, and 50-80%…
Abstract Number: 2018 • 2012 ACR/ARHP Annual Meeting
Juvenile Idiopathic Arthritis in Adulthood: Evaluation of Disease Activity, Damage and Quality of Life
Alessandra Salmaso¹, Lorenzo Ceri², Serena Capannini², Francesco La Torre³, Maurizio Gattinara⁴, Irene Pontikaki¹, Pier Luigi Meroni⁵, Fernanda Falcini² and Valeria Gerloni¹, ¹Pediatric Rheumatology, G. Pini Institute, Department and Chair of Rheumatology, Milan, Italy, ²Department of Internal Medicine, Rheumatology Section, Transition Clinic, University of Florence, Firenze, Italy, ³DIMIMP-University, Rheumatologic Section, Bari, Italy, ⁴Pediatric Rheumatology, Pediatric Rheumatology, G. Pini Institute, Department and Chair of Rheumatology, Milan, Italy, ⁵Dept. of clinical and community science, Division of Rheumatology, Istituto G. Pini, University of Milan, Milano, Italy
Background/Purpose: : Health outcomes in Juvenile Idiopathic Arthritis (JIA) have been a very active area of research in the past several years. Altogether, the available…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].